Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CLVS

Clovis

$32.52

0.29 (0.90%)

08:33
09/21/18
09/21
08:33
09/21/18
08:33
Recommendations
Clovis analyst commentary at JPMorgan »

Clovis price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Tuesday
CLVS

Clovis

$32.82

0.56 (1.74%)

13:45
09/18/18
09/18
13:45
09/18/18
13:45
Hot Stocks
Clovis, executives charged by SEC with misleading investors about cancer drug »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Monday
CLVS

Clovis

$32.26

0.48 (1.51%)

16:41
09/17/18
09/17
16:41
09/17/18
16:41
Initiation
Clovis initiated at Guggenheim »

Clovis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$34.93

0.43 (1.25%)

, AZN

AstraZeneca

$37.45

-0.17 (-0.45%)

05:25
09/17/18
09/17
05:25
09/17/18
05:25
Recommendations
Tesaro, AstraZeneca, Clovis analyst commentary at Piper Jaffray »

Piper sees Astra's…

TSRO

Tesaro

$34.93

0.43 (1.25%)

AZN

AstraZeneca

$37.45

-0.17 (-0.45%)

CLVS

Clovis

$31.78

-0.47 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

Over a month ago
CLVS

Clovis

$35.20

0.645 (1.87%)

11:00
08/15/18
08/15
11:00
08/15/18
11:00
Options
Notable call spread in Clovis Oncology as shares see strength »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$36.91

0.71 (1.96%)

, BMY

Bristol-Myers

$58.98

-0.4 (-0.67%)

08:12
08/08/18
08/08
08:12
08/08/18
08:12
Hot Stocks
Clovis announces first patient in ATHENA trial of Rubraca and Opdivo »

Clovis (CLVS) announced…

CLVS

Clovis

$36.91

0.71 (1.96%)

BMY

Bristol-Myers

$58.98

-0.4 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 19

    Aug

  • 29

    Oct

CLVS

Clovis

$46.00

1.86 (4.21%)

16:23
08/01/18
08/01
16:23
08/01/18
16:23
Earnings
Clovis reports Q2 adjusted EPS ($1.55), consensus ($1.88) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

CLVS

Clovis

$47.45

2.3 (5.09%)

08:04
07/05/18
07/05
08:04
07/05/18
08:04
Hot Stocks
Clovis announces EMA validation for variation to MA for Rubraca »

Clovis announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$44.85

-0.75 (-1.64%)

, TSRO

Tesaro

$43.99

-1.53 (-3.36%)

08:45
06/27/18
06/27
08:45
06/27/18
08:45
Initiation
Clovis, Tesaro initiated at Barclays »

Clovis transferred with…

CLVS

Clovis

$44.85

-0.75 (-1.64%)

TSRO

Tesaro

$43.99

-1.53 (-3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$43.99

-1.53 (-3.36%)

, CLVS

Clovis

$44.85

-0.75 (-1.64%)

08:41
06/27/18
06/27
08:41
06/27/18
08:41
Upgrade
Tesaro, Clovis rating change at Barclays »

Tesaro upgraded to…

TSRO

Tesaro

$43.99

-1.53 (-3.36%)

CLVS

Clovis

$44.85

-0.75 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.